Provisions of Generic Drugs under Section 3(d) of Indian IP Act: What does Data from the Backward States Reveal?
dc.contributor.author | Kumar, Mrityunjay | |
dc.contributor.author | Bharti Nalin | |
dc.date.accessioned | 2022-06-15T09:46:56Z | |
dc.date.available | 2022-06-15T09:46:56Z | |
dc.date.issued | 2019-12 | |
dc.identifier.citation | 306 - 324 pp | |
dc.identifier.issn | 0971-586X | |
dc.identifier.uri | http://hdl.handle.net/10973/54963 | |
dc.publisher | Gokhale Institute of Politics and Economics (GIPE), Pune (India) | |
dc.relation.ispartofseries | Vol. LXI; Issue 4 | |
dc.title | Provisions of Generic Drugs under Section 3(d) of Indian IP Act: What does Data from the Backward States Reveal? | |
dc.type | Article | |
dc.identifier.accno | av-2019-12-02 |
Files in this item
This item appears in the following Collection(s)
-
GIPE Journal - Artha Vijnana [1391]